Related Experiment Video

Updated: Apr 21, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

1.2K

NCRNA combined therapy as future treatment option for cancer

Cornelia Braicu, Cristina Catana, George A Calin

  • 1Iuliu Hatieganu University of Medicine and Pharmacy, 13 Emil Isac Str., Cluj-Napoca 400349, Romania. ioana.neagoe@umfcluj.ro.

Current Pharmaceutical Design
|October 25, 2014
PubMed

Insights

This review explores using noncoding RNAs for cancer multitherapy. It discusses how microRNAs regulate genes and their potential in overcoming cancer drug resistance for personalized treatment.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Cancer develops through accumulated genetic alterations in coding and noncoding genes.
  • MicroRNAs (miRNAs), a class of noncoding RNAs, regulate gene expression post-transcriptionally.
  • Therapeutic resistance is a significant hurdle in effective cancer treatment.

Purpose of the Study:

  • To review the application of noncoding RNAs in cancer multitherapy.
  • To discuss the role of microRNAs in overcoming drug resistance.
  • To address scientific questions pertinent to personalized cancer therapy.

Main Methods:

  • Literature review on noncoding RNAs and cancer therapy.
  • Analysis of microRNA function in gene regulation and drug resistance.
  • Exploration of concepts in noncoding RNA-based multitherapy.

Main Results:

  • MicroRNAs are key regulators of cellular processes and can influence drug resistance.
  • Noncoding RNAs offer a promising avenue for developing novel cancer treatment strategies.
  • Understanding miRNA mechanisms is crucial for advancing personalized cancer medicine.

Conclusions:

  • Noncoding RNAs, particularly microRNAs, hold significant potential for innovative cancer multitherapy approaches.
  • Targeting microRNAs could help overcome therapeutic resistance in cancer patients.
  • Further research into noncoding RNAs is essential for the future of personalized oncology.

More Related Videos

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.4K
DNA Vector-based RNA Interference to Study Gene Function in Cancer13:10

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

19.7K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
6.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

1.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K